| Cancer: |
| Kidney Cancer Vaccine Shows No Boost in Survival (HealthDay) |
| HealthDay - FRIDAY, July 3 (HealthDay News) -- The new vaccine vitespen
didn't increase recurrence-free survival among kidney cancer patients
who'd had surgery, say U.S. researchers. |
| Kidney cancer vaccine falls short in clinical trial: study (AFP) |
| AFP - A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday. |
| Smokeless Tobacco Products Do Raise Cancer Risk (HealthDay) |
| HealthDay - WEDNESDAY, July 2 (HealthDay News) -- Smokeless tobacco products
(STPs), which include products such as snuff and chew tobacco, do
increase the user's risk of cancer -- just not as much as smoking
does. |
| New Drug Slows Thyroid Cancer (HealthDay) |
| HealthDay - WEDNESDAY, July 2 (HealthDay News) -- An experimental drug that
inhibits tumor blood vessel formation slows the progression of metastatic
thyroid cancer in some patients, an international study finds. |
| Circulating Tumor Cells Reveal Insights Into Lung Cancers (HealthDay) |
| HealthDay - WEDNESDAY, July 2 (HealthDay News) -- A new technique for finding
and analyzing stray cancer cells in the blood of lung cancer patients may
make it possible for doctors to one day not only determine the genetic
"signature" of particular tumors but to monitor changes in those cells and
adjust treatments accordingly. |
| Doctors extract cancer cells from blood sample (Reuters) |
| Reuters - An experimental process that snags lung
cancer cells from a blood sample could give doctors real-time
feedback on the most effective therapy, researchers reported on
Wednesday. |
| Tumor-starving pill helps thyroid cancer: study (Reuters) |
| Reuters - Amgen's once-a-day pill to starve
tumors can help many patients with hard-to-treat thyroid
cancer, either by shrinking tumors or slowing their growth,
researchers reported on Wednesday. |
| Biomarkers needed to gauge passive smoke exposure (Reuters) |
| Reuters - Biological indicators, or
"biomarkers" of exposure to secondhand smoke that can be
analyzed in blood, tissue or other samples, or through imaging
scans are needed to examine whether exposure to secondhand
smoke may cause lung cancer. |
|
